Literature DB >> 12508096

Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4-7, 2001, Hakone, Japan.

Jane W Newburger1, Kathryn A Taubert, Stanford T Shulman, Anne H Rowley, Michael H Gewitz, Masato Takahashi, Brian W McCrindle.   

Abstract

Mesh：

Year:  2003        PMID： 12508096     DOI： 10.1203/00006450-200301000-00026

Source DB:  PubMed          Journal:  Pediatr Res        ISSN： 0031-3998            Impact factor:   3.756


× No keyword cloud information.
  11 in total

1.  Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.

Authors:  M Miura; H Ohki; T Tsuchihashi; H Yamagishi; Y Katada; K Yamada; Y Yamashita; A Sugaya; O Komiyama; H Shiro
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

2.  Primary percutaneous coronary intervention for acute myocardial infarction due to possible sequelae of Kawasaki disease in young adults: a case series.

Authors:  Makoto Ariyoshi; Jun Shiraishi; Masayoshi Kimura; Akihiro Matsui; Mitsuo Takeda; Masayasu Arihara; Masayuki Hyogo; Takatomo Shima; Takashi Okada; Yoshio Kohno; Takahisa Sawada; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

3.  Clinical manifestations vary with different age spectrums in infants with Kawasaki disease.

Authors:  Hao-Chuan Liu; Chiao-Wei Lo; Betau Hwang; Pi-Chang Lee
Journal:  ScientificWorldJournal       Date:  2012-02-15

4.  Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease.

Authors:  Meghan Martin; Brian H Wrotniak; Mark Hicar
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

5.  Kawasaki disease in children and adolescents: clinical data of Kawasaki patients in a western region (Tyrol) of Austria from 2003-2012.

Authors:  Elisabeth Binder; Elke Griesmaier; Thomas Giner; Michaela Sailer-Höck; Juergen Brunner
Journal:  Pediatr Rheumatol Online J       Date:  2014-09-02       Impact factor: 3.054

6.  A cross-sectional retrospective study to analyze the underlying causes and clinical characteristics of children with reactive thrombocytosis at a Korean tertiary medical center.

Authors:  Juhee Shin; Dong Hyun Lee; Nani Jung; Hee Joung Choi; Ye Jee Shim
Journal:  Blood Res       Date:  2018-09-28

Review 7.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

8.  Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease.

Authors:  Sungho Cha; Minjeong Yoon; Yongjoo Ahn; Miyoung Han; Kyung-Lim Yoon
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153

Review 9.  Vasculitis in children.

Authors:  Despina Eleftheriou; Paul A Brogan
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-06       Impact factor: 4.098

Review 10.  Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.

Authors:  Bin Tang; Hang Hong Lo; Cheng Lei; Ka In U; Wen-Luan Wendy Hsiao; Xiaoling Guo; Jun Bai; Vincent Kam-Wai Wong; Betty Yuen-Kwan Law
Journal:  Phytomedicine       Date:  2020-03-18       Impact factor: 5.340
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.